Citius Pharmaceuticals Inc (NASDAQ:CTXR) currently has a daily average trading volume of 2.26M but it saw 2848704 shares traded in last market. With a market cap of 13.41M USD, the company’s current market price of $1.2 came falling about -6.98 while comparing to the previous closing price of $1.29. In past 52 weeks, the stock remained buoying in the range of price level as high as $26.25 and as low as $0.65. In the recent trading on the day, stock has struck highest price mark of $1.16 while lowest mark touched by it was $1.45.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the D. Boral Capital which upgraded the stock as “Buy” in its note to investors issued on December 30, 2024, recommending a price target of $9 for it.
Over the week, CTXR’s stock price is moving 40.63% up while it is 70.70% when we observe its performance for the past one month. Year-to-date it is -92.12% down and over the past year, the stock is showing a downside performance of -70.00%.
The company is expected to be releasing its next quarterly report on 2025-May-14, for which analysts forecasted an EPS of -0.21 while estimate for next year EPS is 1.3. In next quarter, company is expected to be making quarterly sales of $5.76M as analysts are expecting the sales for current fiscal year at $7.67M and seeing the company making $73.04M in sales next year. Moreover, analysts are in estimates of $1.92M for current-quarter revenue.
Currently, Citius Pharmaceuticals Inc’s total number of outstanding shares is 11.17M with 4.41% of that held by the insiders while 5.74% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -70.14% and return on equity (ROE) at -60.06%. It has a 3.21 of forward P/E ratio. Stock’s beta reads 0.98. Stock has a price to book (P/B) ratio of 0.17. Its return on asset (ROA) is -39.63% on average.
